We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
23 hedge funds and large institutions have $9.16M invested in Arcturus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.97% less ownership
Funds ownership: 5.21% → 4.24% (-0.97%)
20% less capital invested
Capital invested by funds: $11.5M → $9.16M (-$2.29M)
30% less funds holding
Funds holding: 33 → 23 (-10)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Holders
23
Holders Change
-10
Holders Change %
-30.3%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
9
Closed
12
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$32K
Top Buyers
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$1.39M |
| 2 |
Morgan Stanley
New York
|
-$288K |
| 3 |
VMI
VHCP Management II
New York
|
-$211K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$161K |
| 5 |
D.E. Shaw & Co
New York
|
-$158K |
